SCHEMBL6663907

SCHEMBL6663907

CCOC(=O)c1cnc2sc(C=O)cc2c1O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 6/20 0.43
MAPT P10636 6/20 0.43
RECQL P46063 2/20 0.43
ALDH1A1 P00352 7/20 0.42
GAA P10253 4/20 0.42
KDM4E B2RXH2 6/20 0.42
HSD17B10 Q99714 3/20 0.42
PKM P14618 1/20 0.42
GLA P06280 3/20 0.41
NPSR1 Q6W5P4 1/20 0.41
DPP4 P27487 2/20 0.41
LMNA P02545 3/20 0.40
MAPK1 P28482 2/20 0.40
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
MEN1 O00255 1/20 0.40
POLB P06746 1/20 0.40
HTT P42858 1/20 0.40
KMT2A Q03164 1/20 0.40
USP2 O75604 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10998213 0.83 MAPT (0.46) HPGDMAPTRECQLALDH1A1GAA
SCHEMBL11579997 0.81 MAPT (0.44) HPGDMAPTRECQLALDH1A1GAA
SCHEMBL7480184 0.81 GABRP (0.45) HPGDMAPTRECQLALDH1A1GAA
SCHEMBL11578876 0.81 MAPT (0.49) HPGDMAPTRECQLALDH1A1GAA
SCHEMBL7019066 0.81 NPSR1 (0.56) HPGDMAPTRECQLALDH1A1GAA
SCHEMBL6844296 0.80 NPSR1 (0.47) HPGDMAPTRECQLALDH1A1GAA
SCHEMBL21708066 0.76 NPSR1 (0.43) HPGDMAPTRECQLALDH1A1GAA
SCHEMBL30916871 0.76 ALDH1A1 (0.47) HPGDMAPTRECQLALDH1A1GAA
SCHEMBL6368861 0.76 ALDH1A1 (0.47) HPGDMAPTRECQLALDH1A1GAA
SCHEMBL11581714 0.73 KDM4E (0.48) HPGDMAPTRECQLALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040110787-A1 Heteroaryl-ethanolamine derivatives as antiviral agents PHARMACIA & UPJOHN COMPANY 2004-06-10 US disclosed
WO-2004022567-A1 HETEROARYL-ETHANOLAMINE DERIVATIVES AS ANTIVIRAL AGENTS PHARMACIA & UPJOHN COMPANY LLC (US) 2004-03-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040110787-A1 Heteroaryl-ethanolamine derivatives as antiviral agents RPL35, ZC3HAV1, RPL5 HPGD 3407/4885MAPT 2999/4885RECQL 1388/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.